Molecular Diagnosis of Infectious Diseases Gregory J. Tsongalis, Ph.D.
|
|
- Lesley Wells
- 6 years ago
- Views:
Transcription
1 Molecular Diagnosis of Infectious Diseases Gregory J. Tsongalis, Ph.D. Professor of Pathology Director, Molecular Pathology Dartmouth Medical School Dartmouth Hitchcock Medical Center Norris Cotton Cancer Center Lebanon, NH
2 CANADA DHMC, Lebanon, NH * * California Boston, MA Texas Florida
3 The Human Genome Project February 2001 A major impact on microbial genomics.
4 Microbial Genomics 1995, first complete genome sequence of a free-living organism, Haemophilus influenzae Since then 1,554 complete bacterial genomes Species pangenome contains set of core genes that are common and set of dispensable genes that are absent in at least one strain. Approximately 90% of bacterial genome codes for protein whereas <2% of human genome codes for protein Relman DA. N Engl J Med 2011;365:
5 Why Molecular Pathology? Genetics previously unavailable tests carrier detection risk assessment Infectious diseases turn-around time inability to culture microscopic interpretation and competency quantitative analysis genotyping Heme/Oncology confirmation minimal residual disease therapeutics Identity testing most polymorphic molecule Therapeutics/PGx
6 Applications of Molecular Analyses to Infectious Diseases Qualitative detection Quantitative detection Identification/speciation Microbial Identity Testing Genotyping/Drug Resistance
7 Molecular Infectious Disease (Molecular Testing Methods) Nucleic acid (DNA, RNA) specimens: Blood CSF Tissue (fresh, frozen FFPE) Urine Stool Amniotic fluid Other body fluids Microbial isolate
8 Nucleic Acid Extraction Technologies Manual Extractions: 1. Make your own buffers 2. ph your own buffers 3. Lab math 4. TAT = 1.5 days 5. Low throughput Automated Extractions: 1. Reagent contracts 2. Consumables 3. Maintenance contracts 4. TAT = minutes 5. Higher throughput
9 Automation of NA Extraction Extracton Type Magnetic silica particles Magnetic charge switch particles Silica vacuum manifold plate Iron oxide particles Silica spin columns Instrument COBAS AmpliPrep, EZI, MagnaPure Compact and LC, Maxwell 16, NucliSens EasyMag iprep Purification Instrument 6100/6700 Automated Nucleic Acid Workstation, QIAxtractor m2000sp QIAcube Persing, et.al Molecular Microbiology Diagnostic Principles and Practice (2 nd Ed.) C. Hill, p123.
10 Extraction Issues to be Considered Specimen type Extraction Method Inhibitors Target sequences (DNA vs RNA) Controls (type and number)
11 Molecular Infectious Disease (Molecular Testing Methods) Nucleic acid probes for culture confirmation and direct detection (DNA and RNA probes) Nucleic acid amplification ( NAT ) technologies Sequence amplification Polymerase chain reaction (PCR) and real time PCR Transcription-mediated amplification (TMA and NASBA) Strand displacement amplification (SDA) Ligase chain reaction (LCR) Loop-Mediated Isothermal Amplification (LAMP) Signal amplification Branched-chain DNA (bdna) Hybrid capture Invader (Cleavase) Sequencing Sanger or Next Generation Microarrays and Mass Spectrometry
12 Controls for Qualitative Molecular Diagnostic Testing Sample Preparation Amplification Detection Extraction control (pre- or post-)? efficiency inhibitors Blank control Negative control Positive control Internal amplification control (IAC) (competitive vs non-competitive)
13 Real-Time PCR Permits rapid target Id; <30 min Eliminate post-pcr processing Highly specific; Hybridization probes Allows multiplexing Permits quantification Signal intensity is directly proportional to the amount of amplified DNA Threshold cycle (Ct) determination; the cycle at which target is first detected
14 Detection Chemistries Intercalating/binding dyes SYBR green I Dual label probes/ Quenched probes -TaqMan (5 nuclease assay) -Molecular beacons, Scorpions -FRET probes
15 Increase in Reporter Signal Reports Amplification of Target
16 Ct: Primary Signal Analysis Threshold Cycle Threshold Value Threshold penetration Threshold Line
17 Melt Curve Analysis Following amplification temperature is slowly increased (ie. 60 o c to 95 o c, 0.2 o c/sec) Strands denature Dye released, fluorescence decreases Melting curve; Temperature (x) vs. Fluorescence (y) Tm function of %GC and length
18 Melt Curve Analysis Target Phase Transition Primer dimer
19 Melt Curve Analysis JCV BKV
20 PCR Testing Steps Sample Preparation Amplification Detection/Analysis Automated extraction + Real Time PCR = STAT DNA Analysis
21 Molecular Infectious Disease (Qualitative) Positive or negative Increased sensitivity Decreased TAT Low to high throughput Becoming more automated Applications are limitless but questionable clinical utility Major impact with real time PCR
22 Qualitative Molecular Infectious Disease Testing (Chlamydia trachomatis) THE SILENT EPIDEMIC Misperception of prevalence Asymptomatic Non-specific symptoms Coinfections Unreliable diagnostic tests Asymptomatic individuals serve as a reservoir of infection Issues: high volume, STD (social), high throughput
23 Abbott LCx System Sample Prep Amplification Detection LCx Thermocycler LCx Analyzer
24 LCR Amplification (LCx MEIA System) MEIA particle linked to enzymatic conversion of fluorescent dyes
25
26 BD Viper (ProbeTec System) GenProbe TIGRIS DTS
27 Molecular Infectious Disease Molecular Diagnostic Methods for C. trachomatis M2000 v2 (Abbott) ProbeTec (BD) Assay Gene Target NAAT Amp. Control Hybrid Capture II (Digene) PACE 2 CT (Gen-Probe) Plasmid (2 targets) Real-time PCR Yes Plasmid SDA Yes Plasmid and genome Hybridization No 23S rrna Hybridization No Aptima Combo 2 23S rrna TMA No Aptima CT 16S rrna TMA No TaqMan48 v2 Plasmid and omp1 PCR Yes
28 Qualitative Molecular Infectious Disease Testing (Non-Kit Based Assays) Home brew (Laboratory Developed Tests) Analyte Specific Reagents Primers > PCR > Gel Real time PCR Near patient testing???
29 Qualitative Molecular Infectious Disease Testing (EBV) Bam HI-W repetitive region (296 bp) Conserved Among EBV Strains
30 NEGATIVE POSITIVE SPECIMEN 1 SPECIMEN 1 SPECIMEN 2 SPECIMEN 2 DNA MARKER EBV BETA-ACTIN
31 Real Time PCR Detection of EBV Target gene = BNT p143orf38 EBV DNA, 5000, 500, 50 and 5 copies/ml
32 Molecular Infectious Disease (Bordetella pertussis) PCR is both sensitive and specific Viability (post treatment still detectable) Use of multiple primer sets Specimen types for PCR testing Nasopharyngeal swab (Dacron not Ca alginate or use of a mucolytic agent to avoid PCR inhibition) Other specimens may serve as alternatives Other laboratory testing (Culture or DFA) Bordet and Gengou (Starch Blood Agar) Antibiotic selection plate (Cephalexin) Synthetic media
33 Bordetella Target Genes Copy# pertussis parapertussis holmesii IS ,000 present not present present IS not present present present PTxs1 1 present present not present
34 Qualitative Molecular Infectious Disease Testing (What did we learn?) Specimen types Extraction efficiencies Automation vs manual Importance of controls Assessing performance characteristics Sensitivity, specificity, precision, accuracy Limit of blank, limit of detection Armbruster and Pry. Clin Biochem Rev 2008;29 (Si):S49- S52 Regulatory: FDA vs ASR vs RUO
35 Molecular Infectious Disease (Quantitative) How much is present Limit of quantification (LoQ) Automation Low to high throughput Which applications are clinically relevant Is the LLoQ the same as LoD? Why quant vs qual?
36 Molecular Infectious Disease (HIV-1) Qualitative Quantitative Genotyping
37 HIV-1 Subtypes Group M (Major) Subtypes A - H Group O (Outlier) Group N (New)
38 HIV-1 Viral Load Testing Not diagnostic (?) Designed to monitor infection Sensitivity may be higher than proviral DNA PCR Indications Disease progression Prognosis Response to antiviral agents 0.5 log 10 units is considered clinically significant
39 Molecular Assays for the Qualitative Detection of HIV-1 RNA Assay Method Target Application COBAS AmpliScreen HIV-1 Test, v1.5 (IVD) COBAS AmpliPrep/COBAS TaqMan HIV-1 Qualitative Test (RUO) RT-PCR HIV-1 gag gene Qualitative detection of viral RNA from plasma, organs and tissues PCR HIV-1 gag gene Qualitative detection of HIV-1 RNA and proviral DNA in plasma, anticoagulated fresh whole blood and dried blood spots COBAS TaqScreen MPX Test (IVD) PCR Multiple Simultaneous testing for multiple viruses in a single sample: HIV-1 group M, HIV-1 group O, HIV-2, HCV and HBV
40 Molecular Assays for Quantification of HIV-1 RNA Assay Method Target Dynamic Range (copies/ml) Roche Amplicor HIV Monitor v1.5 test, Standard (IVD) Roche Amplicor HIV Monitor v1.5 test, Ultrasensitive (IVD) Roche Cobas AmpliPrep/Cobas TaqMan HIV Test v.1.0 (IVD) Roche Cobas AmpliPrep/Cobas TaqMan HIV Test v.2.0 (IVD) Siemens Versant HIV RNA 3.0 Assay (IVD) Biomerieux NucliSENS EasyQ HIV-1 V2.0 (RUO) Abbott RealTime HIV-1 Assay (IVD) RT-PCR HIV-1 gag gene ,000 RT-PCR HIV-1 gag gene ,000 Real-time PCR - TaqMan HIV-1 gag gene 48 10,000,000 Real-time PCR - TaqMan HIV-1 gag gene, LTR 20 10,000,000 bdna HIV-1 pol gene ,000 NASBA HIV-1 gag gene 25 10,000,000 Real-time PCR HIV-1 integrase gene 40 10,000,000
41 Viral Load Testing Interpretation of Results Results should be presented as Log 10 Values Prevents clinicians from over interpreting small variations in viral load Changes in viral load must exceed 0.5 log 10 (3 fold) to represent biologically relevant changes in viral replication Due to differences in performance, viral load should be quantified at follow-up by the same version of the same assay that was used initially
42 Viral Load Testing Interpretation of Results Clinical infections can increase viral load by as much as 1 log HSV infections Opportunistic infections Vaccinations Influenza Tetanus Pneumococcal Viral load testing should not be performed for 1 month following such infections
43 copies/ml) Patient Monitoring Initiate Rx Resistance Testing Viral Load (log Compliance 2. Resistance /99 2/99 3/99 5/99 8/99 12/99 4/00 5/00 9/00 2/02 6/02 7/02 8/02
44 HIV-1 Resistance Genotyping Determine the sequence RT and protease genes VGI (FDA approved), ABI, laboratory developed Compare sequence to wild type virus Identify mutations Associate mutations with resistance Knowledge of genetics of resistance Data base, rules based system Different interpretations of same mutations
45 Viral Genotyping Antiretroviral Resistance Testing FDA Approved Systems Assay Name Manufacturer Methodology Truegene HIV-1 Genotyping Kit ViroSeq HIV-1 Genotyping System Siemens Medical Solutions Diagnostics, Tarrytown, NY Abbott Molecular, Des Plaines, IL DNA Sequencing (polyacrylamide gel electrophoresis) DNA Sequencing (Capillary electrophoresis)
46 Viral Genotyping
47 The BK Virus BKV is a member of the polyomavirus family. BKV typically presents with respiratory infection and about 80% of adults are seropositive for BKV antibodies. After primary infection, the virus enters a latent phase in the kidneys, brain, and uterus. The virus usually remains dormant but may reactivate during pregancy, HIV infection, diabetes, or after transplant surgery.
48 BKV Reactivation with Immunosupression Following Bone Marrow Transplant Hemorrhagic Cystitis Following Renal Transplant polyomavirusassociation nephropathy (PVAN or BKVN) Rejected kidney transplant exhibiting BK nephropathy and chronic rejection.
49 Typical intranuclear inclusion pre- and post- micro-dissection a b
50 -df/dt -dt/dt Melt Curve Analysis for BKV/JCV From Microdissected Samples A B Glom Tubules 80 BK virus 60 JC virus 40 NTC Temperature Glom Tubules 80 BK Virus 60 JC Virus 40 NTC Temperature Adeyi OA, Belloni DR, Dufresne SD, Schned AR, Tsongalis GJ. Real-time polymerase chain reaction and laser capture microdissection techniques in the diagnosis of BK virus infection of renal allografts. Am J Clin Pathol 124(4): , 2005
51 Monitoring with PCR BK Viruria and Viremia relatively frequent in immunosuppressed renal transplants Positive PCR results alone not very useful Quantitative Testing (real-time PCR) BKV levels over time With viral level cut-offs BKV PCR useful for determining PVAN (Viscount 2007): In Urine: 100% Sensitivity; 78% Specificity In Plasma: 100% Sensitivity; 91% Specificity
52 Requirements for BKV PCR Quantitative Analytic Specificity: Only detects BKV Analytic Sensitivity: Low limit of detection? Wide dynamic range (concentrations above 10 log10 copies/ml) Specimen type: Urine and plasma
53 Plasma MGB vs. Eragen Assays
54 Urine MGB vs Eragen Assays
55 BKV PCR Obstacles No FDA-approved assays (IVDs): must use laboratory-developed tests (with ASRs) No international standards defining BKV concentrations Limited options for calibrators for standard curve-lack of standarization
56 BKV PCR Obstacles Urine specimens can be difficult: PCR inhibitors Assay should be specific for BKV but detect various strains of BKV equally (robust vs stringent) Gene target Primer/probe location
57 Quantitative Molecular Infectious Disease Testing (What did we learn?) Performance Variants Clinical implications QC of numerical data Automation
58 So what is next in molecular infectious disease testing?
59 Gram positive Bacillus (coccobacillus, diphtheroid ) Anaerobe Non-spore forming Slow grower Non-motile Diagnostic challenges of Propionibacterium acnes McPherson: Henry's Clinical Diagnosis and Management by Laboratory Methods, 22nd ed Saunders Elsevier Accessed Online, 8/31/11. Many strains are indole & catalase positive Frequent contaminant of blood cultures. Isabella Martin, M.D.
60 Habitat
61 Infections Three categories: Acnes in teenagers & adults. Invasive deep-seated infections Pacemakers, valves, shunts. Surgical wound infections Prosthetic joints, spinal hardware. Clinicaladvisor.com Accessed online 8/31/11. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 7th ed Churchill Livingstone Accessed online 8/31/2011.
62 Orthopaedics Quandary 1-2 years Ultra-sound guided joint aspiration with culture + - Implantation of new hardware 6 Wks IV Antibiotics Removal of hardware Revision Arthroplasty + - Oops! Good
63 PCR for P. acnes Real time PCR Taqman assay. Quantitative Ct detect contamination. Internal control: beta-actin? Multi-plexed?
64 The Automation Revolution Continues BD MAX System (HandyLab Jaguar) 1.fully automates cell lysis, nucleic acid extraction, PCR set-up, amplification and detection 2.24 samples per run Enigma Diagnostics Enigma ML 1. portable 2. self-contained 3. ultra-rapid, laboratorystandard results 4. point-of-care testing
65 Smaller is Better Idaho Technologies Film Array IQuum Liat Analyzer
66 PathoGenetix An automated system for identification and strain typing of pathogens in complex sample types. Does not require specific reagents for detection of each pathogen, this approach uses a single reagent set to create genomic barcodes which are then used to detect and identify thousands of strains from hundreds of species. No PCR or other amplification technique is applied. Genome Sequence Scanning (GSS) technology. GSS enables high throughput, single molecule DNA analysis to be used for pathogen identification and characterization in complex biological samples.
67 Biocartis Compact platforms whose ease of use will lower the entry barrier to diagnostic testing. Developing a platform that integrates sample preparation of nucleic acids, amplification, detection, and the generation of a result without user intervention and a detection platform that includes encoded micro carriers, a micofluidic cartridge, and an instrument for low to high multiplexing detection of biomarkers.
68 Lumora BART (Bioluminescent Assay in Real-Time) is a novel reporter system which is used with isothermal nucleic acid amplification technologies. Easy-to-use, affordable, robust hardware.
69 What if.. Miniaturize Low cost Fast Multiplex Smart phone ready
70 DHMC Molecular Pathology Laboratory and Translational Research Program Samantha Allen Betty Dokus Susan Gallagher Carol Hart Arnold Hawk Claudine Lefferts, Ph.D. Joel Lefferts, Ph.D. Rebecca O Meara Elizabeth Reader Mary Schwab Heather Steinmetz Laura Tafe, M.D. Brian Ward Eric York
Molecular Diagnosis Future Directions
Molecular Diagnosis Future Directions Philip Cunningham NSW State Reference Laboratory for HIV/AIDS & Molecular Diagnostic Medicine Laboratory, SydPath St Vincent s Hospital Sydney Update on Molecular
More informationTrends in molecular diagnostics
Trends in molecular diagnostics Detection of target genes of interest Quantification Infectious diseases HIV Hepatitis C & B TB / MAC Cytomegalovirus Herpes simplex Varicella zoster CT/GC HPV Profiling
More informationInnovations in nucleic acid amplification technologies. Automated platforms for NAT. Microfluidics Digital PCR Innovations in nucleic acid microarrays
About the author Disclaimer EXECUTIVE SUMMARY Molecular diagnostic technologies Healthcare-associated infections Sexually transmitted HPVs HIV and hepatitis viruses Market outlook and forecasts Molecular
More informationResults of the College of American Pathologists (CAP) Proficiency Program for CMV, EBV, and BKV Viral Load Testing
2009 College of American Pathologists. The College does not permit reproduction of any substantial portion of the material in this Report without its written authorization. The College hereby authorizes
More informationInstructions for Use. RealStar Influenza Screen & Type RT-PCR Kit /2017 EN
Instructions for Use RealStar Influenza Screen & Type RT-PCR Kit 4.0 05/2017 EN RealStar Influenza Screen & Type RT-PCR Kit 4.0 For research use only! (RUO) 164003 INS-164000-EN-S01 96 05 2017 altona
More informationTechnical Bulletin No. 161
CPAL Central Pennsylvania Alliance Laboratory Technical Bulletin No. 161 cobas 6800 HIV-1 Viral Load Assay - New Platform - June 1, 2017 Contact: Heather Habig, MLS (ASCP) CM, MB CM, 717-851-1422 Operations
More informationDiagnostic Methods of HBV infection. Zohreh Sharifi,ph.D of Virology Research center, Iranian Blood Transfusion Organization (IBTO)
Diagnostic Methods of HBV infection Zohreh Sharifi,ph.D of Virology Research center, Iranian Blood Transfusion Organization (IBTO) Hepatitis B-laboratory diagnosis Detection of HBV infection involves
More informationUPDATE MOLECULAR DIAGNOSTICS IN SEXUAL HEALTH. Dr Arlo Upton Clinical Microbiologist Labtests Auckland
UPDATE MOLECULAR DIAGNOSTICS IN SEXUAL HEALTH Dr Arlo Upton Clinical Microbiologist Labtests Auckland Talk outline Chlamydia trachomatis NAAT What does a positive test mean Interpreting low level positives
More informationWHO Prequalification of Diagnostics Programme PUBLIC REPORT. Product: VERSANT HIV-1 RNA 1.0 Assay (kpcr) Number: PQDx
WHO Prequalification of Diagnostics Programme PUBLIC REPORT Product: VERSANT HIV-1 RNA 1.0 Assay (kpcr) Number: PQDx 0115-041-00 Abstract The VERSANT HIV-1 RNA 1.0 Assay (kpcr) with product codes 10375763,
More informationLack of Significant Co-Activation of BKV and CMV in Renal Transplant Patients: An Institutional Experience
Volume 1, Issue 1, pp: 1-6 Research Article Introduction Open Access Lack of Significant Co-Activation of BKV and CMV in Renal Transplant Patients: An Institutional Experience Minh-Thu Nguyen, BS 1, Phylicia
More informationInstructions for Use. RealStar Influenza S&T RT-PCR Kit /2017 EN
Instructions for Use RealStar Influenza S&T RT-PCR Kit 3.0 01/2017 EN RealStar Influenza S&T RT-PCR Kit 3.0 For research use only! (RUO) 163003 INS-163000-EN-S02 96 01 2017 altona Diagnostics GmbH Mörkenstr.
More informationNew HIV Tests and Algorithm: A change we can believe in
New HIV Tests and Algorithm: A change we can believe in Esther Babady, PhD, D (ABMM) Memorial Sloan-Kettering Cancer Center New York, New York Learning Objectives After this presentation you should be
More informationMicropathology Ltd. University of Warwick Science Park, Venture Centre, Sir William Lyons Road, Coventry CV4 7EZ
www.micropathology.com info@micropathology.com Micropathology Ltd Tel 24hrs: +44 (0) 24-76 323222 Fax / Ans: +44 (0) 24-76 - 323333 University of Warwick Science Park, Venture Centre, Sir William Lyons
More informationLaboratory for Clinical and Biological Studies, University of Miami Miller School of Medicine, Miami, FL, USA.
000000 00000 0000 000 00 0 bdna () 00000 0000 000 00 0 Nuclisens () 000 00 0 000000 00000 0000 000 00 0 Amplicor () Comparison of Amplicor HIV- monitor Test, NucliSens HIV- QT and bdna Versant HIV RNA
More informationChlamydia trachomatis
Chlamydia trachomatis 2012 EQA Programme A Final Report QAB004101 (CTDNA12A) Dr Anton M van Loon Scientific Experts on behalf of QCMD Report authorised by the QCMD Executive in May 2012 A UKAS accredited
More informationWHO Prequalification of In Vitro Diagnostics PUBLIC REPORT. Product: Alere q HIV-1/2 Detect WHO reference number: PQDx
WHO Prequalification of In Vitro Diagnostics PUBLIC REPORT Product: Alere q HIV-1/2 Detect WHO reference number: PQDx 0226-032-00 Alere q HIV-1/2 Detect with product codes 270110050, 270110010 and 270300001,
More informationCALIBRATION OF ANALYTICAL STANDARDS FOR HBV-DNA, HCV-RNA AND HIV-1 RNA IN GENOME COPIES BY A REFERENCE METHOD
CALIBRATION OF ANALYTICAL STANDARDS FOR HBV-DNA, HCV-RNA AND HIV-1 RNA IN GENOME COPIES BY A REFERENCE METHOD AAJ van Drimmelen, E.R. Bax and W.G.V. Quint, BioQControl (BQC), Delft Diagnostic Laboratories
More informationWHO Prequalification of Diagnostics Programme PUBLIC REPORT
WHO Prequalification of Diagnostics Programme PUBLIC REPORT Product: COBAS AmpliPrep/COBAS TaqMan HIV-1 Test, version 2.0 (TaqMan 48) Number: PQDx 0126-046-00 Abstract The COBAS AmpliPrep/COBAS TaqMan
More informationControls for Chlamydia trachomatis and Neisseria gonorrhoea
Controls for Chlamydia trachomatis and Neisseria gonorrhoea Mark Manak, Ph.D., Phil Moen, Ph.D., Bharathi Anekella, Ph.D SeraCare Life Sciences Gaithersburg, MD USA SoGAT Clinical Diagnostic Meeting NIBSC,
More informationaltona RealStar Instructions for Use RealStar CMV PCR Kit /2017 EN DIAGNOSTICS
altona DIAGNOSTICS Instructions for Use RealStar CMV PCR Kit 1.2 08/2017 EN RealStar RealStar CMV PCR Kit 1.2 For research use only! (RUO) 021202 INS-021200-EN-S01 48 08 2017 altona Diagnostics GmbH Mörkenstr.
More informationFifteen years of molecular EQA: progress and challenges
Fifteen years of molecular EQA: progress and challenges Anton M van Loon 1, Stuart West 2 and Paul Wallace 2 1 Department of Virology, UMC Utrecht, The Netherlands 2 QCMD, Glasgow, Scotland Key Issues
More informationChlamydia trachomatis
Chlamydia trachomatis 2012 EQA Programme A Final Report QAB004101 (CTDNA12A) Version 2 Dr Anton M van Loon Scientific Experts on behalf of QCMD Report authorised by the QCMD Executive in May 2012 A UKAS
More informationQUALITY CONTROL for MOLECULAR DIAGNOSTICS Quality issues highlighted through international external quality assessment
QUALITY CONTROL for MOLECULAR DIAGNOSTICS Quality issues highlighted through international external quality assessment William G MacKay PhD Neutral Office Coordinator QCMD The Altum Building, Todd Campus
More informationFor purification of viral DNA and RNA from a wide range of sample materials
QIAamp virus kits For purification of viral DNA and RNA from a wide range of sample materials Automatable on QIAGEN s proven QIAamp Kits set the standard for purification of viral DNA and RNA. QIAamp virus
More informationControls for Chlamydia trachomatis and Neisseria gonorrhoea
Controls for Chlamydia trachomatis and Neisseria gonorrhoea Mark Manak, Ph.D., SeraCare Life Sciences Gaithersburg, MD USA SoGAT Clinical Diagnostic Meeting NIBSC, South Mimms, UK June 25, 2008 C. trachomatis
More informationPanther has new prey
Raising the Bar for Performance Testing Panther has new prey The Aptima HIV-1 Quant Dx assay leads the hunt for HIV-1 diagnosis and viral load monitoring. Freedom to work the way you choose Run what assays
More informationHIV-1 Viral Load Real Time (RG)
-1 Viral Load Real Time (RG) Real Time RT-PCR type 1 RNA quantification assay MSP Reg. pending Valdense 3616. 11700. Montevideo. Uruguay. phone (598) 2 336 83 01. Fax (598) 2 336 71 60. Info@atgen.com.uy
More informationNew CT/GC Tests. CDC National Infertility Prevention Project Laboratory Update Region II May 13-14, 2009
CDC National Infertility Prevention Project Laboratory Update Region II May 13-14, 2009 Richard Steece, Ph.D., D(ABMM) DrRSteece@aol.com New CT/GC Tests New Nucleic Acid Amplification Tests (NAATs) for
More informationCMV Diagnostic Strategies: Current and Future
CMV Diagnostic Strategies: Current and Future Tony Mazzulli, MD, FRCPC, FACP Microbiologist-in-Chief Mount Sinai Hospital & University Health Network, Toronto Faculty/Presenter Disclosure Relationships
More informationHBV PUBLIC HEALTH IMPLICATIONS
جزايری دکتر سيد محمد آزمايشگاه ھپاتيت B -دانشکده بھداشت ويروس شناسی- گروه دانشگاه علوم پزشکی تھران کنگره ارتقا کيفيت- ١٣٩٢ HBV PUBLIC HEALTH IMPLICATIONS 2 billion people have been infected by HBV worldwide.
More informationWHO Prequalification of Diagnostics Programme PUBLIC REPORT. Product: Abbott RealTime HIV-1 (m2000sp) Number: PQDx
WHO Prequalification of Diagnostics Programme PUBLIC REPORT Product: Abbott RealTime HIV-1 (m2000sp) Number: PQDx 0145-027-00 Abstract Abbott RealTime HIV-1 (m2000sp) assay with product code 2G31, which
More informationQuantification of HBV, HCV genotype and HIV subtype panels
Quantification of HBV, HCV genotype and HIV subtype panels Harry van Drimmelen 1,2, Wim Quint 2, Nico Lelie 3 and the international NAT study group 1. Biologicals Quality Control, 2. DDL Diagnostic Laboratory,
More informationNew diagnostic tests for sexually transmitted infections. Jens Van Praet 30/11/2018
New diagnostic tests for sexually transmitted infections Jens Van Praet 30/11/2018 Introduction Data from our national microbiological labs suggest STIs are an important clinical issue Correlation with
More informationMultiplex-PCR in clinical virology benefits and limitations. Weihenstephan Multiplex-PCR the concept:
Multiplex-PCR in clinical virology benefits and limitations ans itschko, elga Mairhofer, Anna-Lena Winkler Max von Pettenkofer-Institute Department of Virology Ludwig-Maximilians-University, Munich Weihenstephan
More informationAlere Technologies GmbH
Alere Technologies GmbH Mobile Smart Instruments for Automated Image Analysis and Point of Care Diagnosis April 2011 Alere Technologies GmbH Alere Technologies GmbH Based in Jena, Thuringia, Germany ~300
More informationSTOCS-H Scottish TOC Study HPV test comparison
STOCS-H Scottish TOC Study HPV test comparison What is entailed? Trial of new HPV tests on residual sample after HC2 result obtained, reported and acted on Complements English Sentinel Sites HPV Multi-test
More informationSimple Solutions for Patient Monitoring. Maximum Flexibility 2 Configuration: 8 to 1000 viral load tests/day 2 Sample: Plasma/DBS
Simple Solutions for Patient Monitoring What is the interest of having a high level of sensitivity? Higher sensitivity means you are able to offer better patient monitoring, particularly in the low viral
More informationMOLECULAR DIAGNOSTICS OF INFECTIOUS DISEASES: STABILITY OF SPECIMENS DURING PREANALYTICS
MOLECULAR DIAGNOSTICS OF INFECTIOUS DISEASES: STABILITY OF SPECIMENS DURING PREANALYTICS OVERVIEW (1) Background (2) Sample collection vials useful for different types of specimens (3) Stability of nucleic
More informationBEIPH Final Report. EQA Programme 2011 Chlamydia trachomatis (CTDNA11A) William G Mackay on behalf of QCMD and its Scientific Council April 2011
BEIPH Final Report EQA Programme 2011 Chlamydia trachomatis (CTDNA11A) William G Mackay on behalf of QCMD and its Scientific Council April 2011 Not to be reproduced or quoted without permission of QCMD.
More informationTechnical Bulletin No. 162
CPAL Central Pennsylvania Alliance Laboratory Technical Bulletin No. 162 cobas 6800 HCV Viral Load Assay - New Platform - June 1, 2017 Contact: Heather Habig, MLS (ASCP) CM, MB CM, 717-851-1422 Operations
More informationHIV viral load testing in the era of ART. Christian Noah Labor Lademannbogen, Hamburg
HIV viral load testing in the era of ART Christian Noah Labor Lademannbogen, Hamburg 1 Life expectancy of patients on ART Data from the UK Collaborative HIV Cohort (UK CHIC) Requirements: Early diagnosis
More informationKhalid Alquthami (Correspondence) Regional Lab, Makkah. Saudi Arabia
1 Regional Lab, Makkah. Saudi Arabia stract: Clinical specificity and genotype/subtype detection of viruses using the Cobas TaqScreen MPX system V 2.0, which is a nucleic acid test (NAT) that uses multiples
More informationA novel isothermal amplification approach for rapid identification of BCR-ABL fusion genes at onset:
A novel isothermal amplification approach for rapid identification of BCR-ABL fusion genes at onset: Josh Glason: Sales Manager, DiaSorin Australia Pty Ltd September 6, 2014 This product is not currently
More informationSchedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK
2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK Royal Liverpool & Broadgreen University Hospitals NHS Trust Department of Virology Liverpool Clinical Laboratories Royal Liverpool and Broadgreen
More informationMENU PRODUCT MOLECULAR. International Product Listing. Simplexa Molecular Kits Integrated Cycler Molecular Reagents and Primer Pairs
International Product Listing MOLECULAR PRODUCT MENU Simplexa Molecular Kits Integrated Cycler Molecular Reagents and Primer Pairs Products are not intended for donor screening. Simplexa Molecular Kits
More informationViral Hepatitis Diagnosis and Management
Viral Hepatitis Diagnosis and Management CLINICAL BACKGROUND Viral hepatitis is a relatively common disease (25 per 100,000 individuals in the United States) caused by a diverse group of hepatotropic agents
More information(DNA) Real-time PCR. Exicycler 96 Rotor-Gene Q/6000 PCR
Real-Time (DNA) Real-time Exicycler 96 Rotor-Gene Q/6000 IU Mix1 Mix2 IU/μl IU/μl IU/μl IU/μl IU/μl IPC NTC C 1 Lot# 2 Freeze & thawing 1 MSDS: Material Safety Data Sheets (TaqMan Real-time ' FAM ' BHQ1
More informationDiagnostic Methods of HBV and HDV infections
Diagnostic Methods of HBV and HDV infections Zohreh Sharifi,ph.D Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine Hepatitis B-laboratory diagnosis Detection
More informationHepatitis C Virus (RNA)A
Hepatitis C Virus (RNA)A 2012 EQA Programme Final Report QAV994112 (HCVRNA12A) Professor Jacques Izopet Scientific Expert on behalf of QCMD Report authorised by the QCMD Executive in July 2012 A UKAS accredited
More informationFEDERAL PUBLIC SERVICE, HEALTH, FOOD CHAIN SECURITY AND ENVIRONMENT CLINICAL BIOLOGY COMMISSION CLINICAL BIOLOGY SECTION
IPH J. Wytsmanstreet 14 B-1050 Brussels FEDERAL PUBLIC SERVICE, HEALTH, FOOD CHAIN SECURITY AND ENVIRONMENT CLINICAL BIOLOGY COMMISSION CLINICAL BIOLOGY SECTION External Quality Assessment for Molecular
More information4. RED AND BLUE TOP COLLECTION SWABS WILL NO LONGER BE SUPPLIED FOR BACTERIAL CULTURE
Laboratory Testing Update Specimen Transport Changes dated 12-24-14 SEH Laboratory is making significant changes to specimen transports! The Laboratory is introducing new testing platforms along with working
More informationNucleic Acid Amplification Testing for the Diagnosis of TB
Roche Nucleic Acid Amplification Testing for the Diagnosis of TB David Warshauer, PhD Deputy Director, Communicable Diseases Wisconsin State Laboratory of Hygiene 19 th /20 th Century Traditional Algorithm
More informationNorgen s HIV Proviral DNA PCR Kit was developed and validated to be used with the following PCR instruments: Qiagen Rotor-Gene Q BioRad T1000 Cycler
3430 Schmon Parkway Thorold, ON, Canada L2V 4Y6 Phone: 866-667-4362 (905) 227-8848 Fax: (905) 227-1061 Email: techsupport@norgenbiotek.com HIV Proviral DNA PCR Kit Product# 33840 Product Insert Intended
More informationSchedule of Accreditation
Schedule of Accreditation Organisation Name National Virus Reference Laboratory INAB Reg No 326MT Contact Name Eimear Malone Address University College Dublin, Belfield, Dublin Contact Phone No 01-7161319
More informationSchedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK
2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK West of Scotland Specialist Virology Centre New Lister Building Level 5 Glasgow Royal Infirmary 10-16 Alexandra Parade Glasgow G31 2ER Contact:
More informationNon-competitive Internal Control Concept for PCR-based Qualitative Assays
Christian O. Simon Roche Molecular Diagnostics Rotkreuz, CH Non-competitive Internal Control Concept for PCR-based Qualitative Assays 23 rd SoGAT Meeting, 16 th 17 th April, 2012, Vilnius, Lithuania Design
More informationHEV Assay Development Update
HEV Assay Development Update Jeffrey M. Linnen, Ph.D. Senior Director, Research & Development Hologic Gen-Probe, San Diego, California USA IPFA/PEI 20th International Workshop on Surveillance and Screening
More informationDonor Screening in The Region. Vincini GA NRL, Melbourne, Australia
Donor Screening in The Region Vincini GA NRL, Melbourne, Australia NRL Established in 1985 Not-for-profit organisation that exists to support laboratories that perform testing for the diagnosis and management
More informationInfectious Disease Diagnostics
Infectious Disease Diagnostics Tackling Infectious Diseases Uppsala Health Summit - October10 th, 2017 Stephan Jäger, Roche Diagnostics GmbH When to tackle infectious diseases Prevention & action contribution
More informationNew technologies reaching the clinic
New technologies reaching the clinic Martin Däumer May 31, 2018 Deep-sequencing Standard Sanger-sequencing...PQIYMDDHTRE... Ultra-deep-sequencing...PQIYMDDHTRE......PQIYMDDHTRE......PQIYVDDHTRE......PQIYMDDHTRE......PQIYMDDHTRE......PQIYMDDHTRE...
More informationSample Selection, Collection, Transport: Issues & Challenges
Sample Selection, Collection, Transport: Issues & Challenges Jim Dunn, PhD, D(ABMM) Director, Medical Microbiology and Virology Texas Children s Hospital LEARNING OBJECTIVES 1. Identify factors to consider
More informationScottish Bacterial Sexually Transmitted Infections Reference Laboratory (SBSTIRL) User Manual Jan 2018
Scottish Bacterial Sexually Transmitted Infections Reference Laboratory (SBSTIRL) User Manual Jan 2018 Page 1 Contents 1 Introduction Page 3 2 Contact details Page 4 3 Opening hours Page 4 4 Services provided
More informationHuman diagnostics. Better be Sure: Quantify HDV & HBV viral load. RoboGene product family
Human diagnostics Better be Sure: Quantify HDV & HBV viral load. RoboGene product family 2 RoboGene Product Family Improved patient management: Standardized monitoring of HBV DNA and HDV RNA viral load.
More informationAbout the LIAISON MDX
The quality of treatment starts with diagnosis International Molecular Product MENU Simplexa Molecular Kits LIAISON MDX Molecular Reagents Primer Pairs About the LIAISON MDX The LIAISON MDX is an innovative
More informationHIV Viral Load Quality Assessment Program Summary for Panel HIVVL 2018Oct26
1 National Laboratory for HIV Reference Services National HIV and Retrovirology Laboratories National Microbiology Laboratory Public Health Agency of Canada HIV Viral Load Quality Assessment Program Summary
More informationHIV Update in Laboratory Testing. Patricia Slev, PhD, D(ABCC)
HIV Update in Laboratory Testing Patricia Slev, PhD, D(ABCC) Objectives Explain the advances in HIV diagnostics, including fourth generation Ag/Ab combination HIV screening assays Describe the new CDC
More informationWHO Prequalification of Diagnostics Programme PUBLIC REPORT
WHO Prequalification of Diagnostics Programme PUBLIC REPORT Product: COBAS AmpliPrep/COBAS TaqMan HIV-1 Qualitative Test, version 2.0 (TaqMan 48) Number: PQDx 0221-046-00 Abstract COBAS AmpliPrep/COBAS
More informationDiagnostics: Bench to Bedside Pathway
Diagnostics: Bench to Bedside Pathway Rosanna W Peeling Professor and Chair, Diagnostic Research Director, International Diagnostics Centre London School of Hygiene & Tropical Medicine www.idx-dx.org The
More informationLiquid Biopsy Applications on the Idylla Fully Integrated Sample-to-Result MDx System
Liquid Biopsy Applications on the Idylla Fully Integrated Sample-to-Result MDx System Erwin Sablon, Head of R&D, Biocartis NV World CDx, Boston, September 10 th 2015 0 About Biocartis Innovative molecular
More informationWHO Prequalification of Diagnostics Programme PUBLIC REPORT
WHO Prequalification of Diagnostics Programme PUBLIC REPORT Product: COBAS AmpliPrep/COBAS TaqMan HIV-1 Qualitative Test, version 2.0 (TaqMan 96) Number: PQDx 0200-046-00 Abstract COBAS AmpliPrep/COBAS
More informationHIV immunological and virological monitoring tools. Pascale Ondoa 5th INTEREST workshop Dar es Salam Thursday 12th, 2011
HIV immunological and virological monitoring tools Pascale Ondoa 5th INTEREST workshop Dar es Salam Thursday 12th, 2011 Monitoring HIV disease progression and treatment When to start ART? CD4 count When
More informationMultilaboratory Evaluation of Real-Time PCR Tests for Hepatitis B Virus DNA Quantification
JOURNAL OF CLINICAL MICROBIOLOGY, Aug. 2011, p. 2854 2858 Vol. 49, No. 8 0095-1137/11/$12.00 doi:10.1128/jcm.00471-11 Copyright 2011, American Society for Microbiology. All Rights Reserved. Multilaboratory
More informationHepatitis B Antiviral Drug Development Multi-Marker Screening Assay
Hepatitis B Antiviral Drug Development Multi-Marker Screening Assay Background ImQuest BioSciences has developed and qualified a single-plate method to expedite the screening of antiviral agents against
More informationncounter TM Analysis System
ncounter TM Analysis System Molecules That Count TM www.nanostring.com Agenda NanoString Technologies History Introduction to the ncounter Analysis System CodeSet Design and Assay Principals System Performance
More informationThe Application of molecular POCT for Influenza and Group A Strep Detection
The Application of molecular POCT for Influenza and Group A Strep Detection Gregory J. Berry, Ph.D., D(ABMM) Assistant Professor, Pathology and Laboratory Medicine Zucker School of Medicine at Hofstra/Northwell
More informationon October 4, 2018 by guest
JCM Accepts, published online ahead of print on 3 July 2012 J. Clin. Microbiol. doi:10.1128/jcm.01249-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 Title: Performance of
More informationof clinical laboratory diagnosis in Extra-pulmonary Tuberculosis
New approaches and the importance of clinical laboratory diagnosis in Extra-pulmonary Tuberculosis Bahrmand.AR, Hadizadeh Tasbiti.AR, Saifi.M, Yari.SH, Karimi.A, Fateh.A, Tuberculosis Dept. Pasteur Institute
More informationUse of Viral Load Testing in Managing CMV Infections in SOTR
Use of Viral Load Testing in Managing CMV Infections in SOTR Angela M. Caliendo, MD, PhD, FIDSA Professor and Vice Chair, Medicine Alpert Medical School of Brown University Providence, RI Disclosures Scientific
More informationNorgen s HIV proviral DNA PCR Kit was developed and validated to be used with the following PCR instruments: Qiagen Rotor-Gene Q BioRad icycler
3430 Schmon Parkway Thorold, ON, Canada L2V 4Y6 Phone: (905) 227-8848 Fax: (905) 227-1061 Email: techsupport@norgenbiotek.com HIV Proviral DNA PCR Kit Product # 33840 Product Insert Background Information
More informationPerformance of Chlamydia trachomatis and Neisseria gonorrhoeae nucleic acid amplification assays using low level controls
Performance of Chlamydia trachomatis and Neisseria gonorrhoeae nucleic acid amplification assays using low level controls 7 th International Symposium on Molecular Diagnostics, Graz, Austria May 2008 Phillip
More informationTEST REQUEST INFORMATION- VIROLOGY
Chlamydia/ Gonorrhea Nucleic Acid Amplification VC75 Qualitative Nucleic Acid Amplification SPECIMEN: Genital swab or first catch urine CONTAINER:GEN-PROBE APTIMA 2 Combo swab transport tube or urine transport
More information2018 HIV and HCV Diagnostic Testing Survey
2018 HIV and HCV Diagnostic Testing Survey This survey is designed to capture the 2017 HIV and HCV testing practices in state and local public health laboratories (PHL). The results of the survey will
More informationStability of native, lyophilized and inactivated standards
Stability of native, lyophilized and inactivated standards Harry van Drimmelen Bio Quality Control, Heiloo, Netherlands Satellite Meeting before IPFA-PEI 25 th Workshop Twenty-five Years Standardization
More informationTB NAAT testing at the Los Angeles County Public Health Laboratory
TB NAAT testing at the Los Angeles County Public Health Laboratory Hector Rivas Public Health Microbiology Supervisor II Los Angeles County Public Health Laboratory hrivas@ph.lacounty.gov April 2012 1
More informationQuantitative Nucleic Acid Amplification Methods for Viral Infections
Papers in Press. Published November 17, 2014 as doi:10.1373/clinchem.2014.223289 The latest version is at http://hwmaint.clinchem.org/cgi/doi/10.1373/clinchem.2014.223289 Clinical Chemistry 61:1 000 000
More informationWHO recommendations. Diagnostic testing in infants
WHO recommendations Diagnostic testing in infants Recommendations 2- testing in infants Intervention Reco QoE Comment At or around 6 weeks of age is most efficient time at which to perform a viral test
More informationWHO Prequalification of Diagnostics Programme PUBLIC REPORT. Product: Abbott RealTime HIV-1 (m2000sp) Number: PQDx
WHO Prequalification of Diagnostics Programme PUBLIC REPORT Product: Abbott RealTime HIV-1 (m2000sp) Number: PQDx 0145-027-00 Abstract The Abbott RealTime HIV-1 (m2000sp) assay with product code 2G31 (which
More informationNew Generation of Nucleic Acid Testing. Michele Owen, Ph.D Division of HIV/AIDS Prevention Centers for Disease Control & Prevention
New Generation of Nucleic Acid Testing Michele Owen, Ph.D Division of HIV/AIDS Prevention Centers for Disease Control & Prevention Percentage (%) Persons Living with Diagnosed or Undiagnosed HIV Infection
More informationEvaluation of run controls for cobas 6800 MPX and HEV assay
Evaluation of run controls for cobas 6800 MPX and HEV assay Marco Koppelman Head of Nucleic Acid testing (NAT) laboratory, National Screening laboratory of Sanquin (NSS) in the Netherlands Satellite Meeting
More informationVQA HIV DNA Control SOP Version 5.0 HIV DNA Testing 13 March 2012
1. PRINCIPLE 1.1. The Virology Quality Assurance (VQA) Laboratory provides external cell pellet controls for use in the validation of assays that detect HIV proviral DNA. 1.2. HIV seronegative peripheral
More informationEvaluation of the new Abbott mplus feature: Impact on clinical laboratory efficiencies with Abbott RealTime HIV-1, HCV, HBV and CT/NG assays
JCM Accepts, published online ahead of print on 2 October 2013 J. Clin. Microbiol. doi:10.1128/jcm.01672-13 Copyright 2013, American Society for Microbiology. All Rights Reserved. 1 2 3 4 5 Evaluation
More informationB19 Virus EQA Programme Final Report QAV (B19DNA14)
B19 Virus 2014 EQA Programme Final Report QAV034116 (B19DNA14) Prof. Hubert GM Niesters Scientific Expert on behalf of QCMD Report authorised by the QCMD Executive in July 2014 A UKAS accredited proficiency
More informationExperience with Standardisation of Blood Virology NAT. Clare Morris Division of Retrovirology National Institute for Biological Standards and Control
Experience with Standardisation of Blood Virology NAT Clare Morris Division of Retrovirology National Institute for Biological Standards and Control Background of Blood Virology Standardisation In the
More informationPRODUCT# PRODUCT NAME VOLUME
The quality of treatment starts with diagnosis International Molecular Product MENU Simplexa Molecular Kits LIAISON MDX Molecular Reagents Primer Pairs About the LIAISON MDX The LIAISON MDX is an innovative
More informationAMPLIRUN TOTAL A RELIABLE QUALITY CONTROL SOURCE FOR NUCLEIC ACID TESTS
AMPLIRUN TOTAL A RELIABLE QUALITY CONTROL SOURCE FOR NUCLEIC ACID TESTS Take Control, Molecular Control. 02 04 05 06 06 07 08 08 AMPLIRUN TOTAL RESPIRATORY INFECTIONS TUBERCULOSIS INFECTIONS GASTROINTESTINAL
More informationIt takes more than just a single target
It takes more than just a single target As the challenges you face evolve... HIV mutates No HIV-1 mutation can be considered to be neutral 1 Growing evidence indicates all HIV subtypes may be prone to
More informationComplicated viral infections
Complicated viral infections Clinical case discussion Diagnostic dilemmas NSW State Reference Laboratory for HIV St Vincent s Hospital Sydney Diagnostic dilemmas Indeterminate or discordant serology (western
More informationList the steps in the fourth generation HIV screening algorithm Describe the relationship between rapid HIV antibody tests and the fourth generation
Alere (honoraria) List the steps in the fourth generation HIV screening algorithm Describe the relationship between rapid HIV antibody tests and the fourth generation testing algorithm Interpret challenging
More informationRetrospective and Prospective Verification of the Cepheid Xpert Flu Assay
JCM Accepts, published online ahead of print on 20 July 2011 J. Clin. Microbiol. doi:10.1128/jcm.01162-11 Copyright 2011, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights
More information